Learn about Juvista that can significantly reduce existing scars with only two injections.

The Era of Agel is transforming the wellness industry by merging cutting edge science in nutrition with revolutionary technology and convenience.

Blue Membranes and Goodman announce the closing of collaborative product development and a worldwide licence, manufacturing and supply agreement for BlueM's proprietary nano-composite drug-delivery coating technology.

Campaign launched to rally Multiple Sclerosis patients in potential class action lawsuit against the manufacturer of pharmaceutical drugs Tysabri and Avonex.

Internationally-acclaimed neuroscientist/researcher Candace Pert, Ph.D. and research colleague Michael Ruff, Ph.D. report on AIDS research now in clinical trials (for human patients) that promises to reduce the spread of AIDS, prolong life, reverse weight loss and offer earlier intervention.

Michael Bennett, M.D., Honolulu retinal surgeon, is able to offer the first real hope to his patients who face blindness from age-related macular degeneration.

Rimonabant Report to Cover All of the Latest Rimonabant Trial Results and Related News Briefings at American College of Cardiology Meeting in Orlando